Lack of GSK3β activation and modulation of synaptic plasticity by dopamine in 5-HT1A-receptor KO mice

Psychiatric disorders are associated with excitation-inhibition (E-I) balance impairment in the prefrontal cortex. However, how the E-I balance is regulated is poorly known. The E-I balance of neuronal networks is linked to the action of numerous neuromodulators such as dopamine and 5-HT. We investi...

Full description

Saved in:
Bibliographic Details
Published inNeuropharmacology Vol. 113; no. Pt A; pp. 124 - 136
Main Authors Meunier, C.N.J., Cancela, J.-M., Fossier, P.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2017
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Psychiatric disorders are associated with excitation-inhibition (E-I) balance impairment in the prefrontal cortex. However, how the E-I balance is regulated is poorly known. The E-I balance of neuronal networks is linked to the action of numerous neuromodulators such as dopamine and 5-HT. We investigated the role of D2-receptors in tuning the E-I balance in a mouse model of anxiety, the 5-HT1A-receptor KO mice. We focused on synaptic plasticity of excitation and inhibition on layer 5 pyramidal neurons. We show that D2-receptor activation decreases the excitation and favors HFS-induced LTD of excitatory synapses via the activation of GSK3β. This effect is absent in 5-HT1A-receptor KO mice. Our data show that the fine control of excitatory transmission by GSK3β requires recruitment of D2-receptors and depends on the presence of 5-HT1A-receptors. In psychiatric disorders in which the number of 5-HT1A-receptors decreased, therapies should reconsider how serotonin and dopamine receptors interact and control neuronal network activity. •A new link between D2R and 5-HT1AR in regulating the E-I balance and the plasticity.•Functional 5-HT1ARs are needed to allow the “classic” effect of D2R on plasticity.•Loss of GSK3β signaling recruitment by D2Rs when 5-HT1ARs are absent.•Dopamine action could be impaired in human pathologies linked to 5-HT1ARs depletion.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-3908
1873-7064
DOI:10.1016/j.neuropharm.2016.09.025